Research Projects

Kidney Disease

• Subclinical inflammation and fibrosis in the kidney donor as determinants of graft functionality in the medium term after transplantation. Fundación SENEFRO (Sociedad Española de Nefrología). 2026 - 2028. PI: Gloria Alvarez-Llamas

• New non-invasive kidney donor assessment tools to assit in decision making to increase kidney donation rate (OPTIREN). PID2023-149828OB-I00 (Ministerio de Ciencia, Innovación y Universidades). 01/09/2024 - 37/08/2028. PI: Gloria Alvarez-Llamas

• Biological markers predictive of long-term post-transplant renal function: multi-omics approach in donor liquid biopsy. Fundación Mutua Madrileña. 01/12/2021 - 30/11/2026. PI: Gloria Alvarez-Llamas

• Decreasing intestinal absorption of phosphorus as a strategy to slow the progression of chronic kidney disease in primary care patients ICI22/00090 (ISCIII). 01/01/2023 - 31/12/2026. Coordinator: Mariano Rodríguez Portillo 

•  Spain CKD cause (SpaCKDc). PMP21/00109 (ISCIII).  01/01/2022 - 31/12/2025. Coordinator: Alberto Ortiz Arduan

• RICORS2040 (Kidney Disease) RD21/0005/0001 (ISCIII). 01/01/2022 - 31/12/2024. Coordinator: Alberto Ortiz Arduan

• Identification of a molecular profile predictive of albuminuria in hypertensive patients with chronic suppression of the renin-angiotensin system. PI16/01334 (ISCIII). 01/01/2017 - 30/06/2021. PI: Gloria Alvarez-Llamas

• Stratification of normoalbuminuria condition. Urine glycoproteome study and identification of subclinical albuminuria markers. Fundación SENEFRO (Sociedad Española de Nefrología). 23/12/2020 - 22/12/2022. PI: Gloria Alvarez-Llamas

• Identification of a molecular profile predictive of albuminuria development in hypertensive patients with chronic suppression of the renin-angiotensin system. Fundación SENEFRO (Sociedad Española de Nefrología). 01/01/2017 - 31/12/2018. PI: Gloria Alvarez-Llamas

• Spain CKD cause (SpaCKDc). PMP21/00109 (ISCIII). 01/01/2021 - 31/12/2025. PI: Alberto Ortiz

• Comprehensive approach to resistant arterial hypertension: improving diagnosis and treatment and searching for biomarkers of therapeutic response. PI13/01334 (ISCIII). 01/01/2014 - 30/06/2017. PI: Gloria Alvarez-Llamas

Cardiovascular disease

• Aneurisma Aórtico Torácico Idiopático: Interacción Celular y Medicina Personalizada. PI23/00100 (ISCIII). 01/01/2024 - 31/12/2026. PI: Marta Martin-Lorenzo

• Aneurisma de aorta torácica: de los mecanismos aórticos in situ a los marcadores plasmáticos de diagnóstico. CP22/00100 (ISCIII, Miguel Servet program). 01/02/2023 - 31/01/28. PI: Marta Martin-Lorenzo

• Descifrando el metabolismo del Aneurisma Torácico Aórtico mediante imagen molecular: desde el desarrollo silente a la identificación de marcadores de diagnóstico. PI20/01103 (ISCIII). 01/01/2121 - 31/12/2024. PI: Gloria Alvarez-Llamas

• Targeted and untargeted molecular correlative imaging for the investigation of the in situ metabolism of atherosclerosis (COST European Cooperation in Science & Technology). 2021. PIs: Gloria Alvarez-Llamas, Benjamin Balluff (M4I Maastricht)

• Proteomic and metabolomic profile associated to cardiovascular risk in urine from patients with and without chronic kidney disease. Setting the basis for an early prediction. IDCSalud. 01/01/2014 - 31/12/2016. PI: Gloria Alvarez-Llamas

• Atherosclerosis in depth from proteomics side. Novel tools and strategies for biomarker discovery (ISCIII). 22/03/2010 - 23/03/2013. PI: Gloria Alvarez-Llamas

• Search for novel proteins and metabolites involved in atherothrombosis by proteomics. Cardiovascular initiative of HUPO (The Human Proteome Organization). PI080970 (ISCIII). 01/01/2009 - 31/12/2011. PI: Fernando Vivanco

Other pathologies (ELA, colon cancer)

• ELA desde una aproximación ómico-molecular: Identificación de dianas de diagnóstico temprano, pronóstico y monitorización terapéutica. FUNDELA. 19/10/2018 - 18/10/2019. PI: Gloria Alvarez-Llamas

• DIABETESCANCERCONNECT: targeting common inflammatory markers and signaling pathways in diabetes mellitus and cancer. PIE13/00051 (ISCIII). 01/01/2014 - 30/06/2017. PI: Gloria Alvarez-Llamas. Coordinator: Jesus Egido